Clinical trial

Evaluation of the Efficacy of Early Implantation of a Percutaneous Left…

NCT05366452 · Assistance Publique Hopitaux De Marseille, Other · Recruiting

Key facts

NCT number NCT05366452
Title Evaluation of the Efficacy of Early Implantation of a Percutaneous Left Ventricular Assist Devices in Acute Coronary Syndrome Complicated by Cardiogenic Shock Compared to Conventional Therapy: a Prospective, Multicenter, Randomized, Controlled and Open-label Clinical Trial
Official title Evaluation of the Efficacy of Early Implantation of a Percutaneous Left Ventricular Assist Devices in Acute Coronary Syndrome Complicated by Cardiogenic Shock Compared to Conventional Therapy: a Prospective, Multicenter, Randomized, Controlled and Open-label Clinical Trial
Acronym ULYSS
Lead sponsor Assistance Publique Hopitaux De Marseille, Other
Status Recruiting
Study type Interventional
Conditions Cardiogenic Shock
Intervention type Device, Other
Interventions IMPELLA CP, Conventional therapy
Enrollment 204
Start date Dec 19, 2022
Primary completion Jun 1, 2026
Completion Dec 1, 2026
First posted May 9, 2022
Last update posted Jan 25, 2023
Countries France

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies